Free Trial

MetLife, Inc. (NYSE:MET) Shares Bought by Bridgewater Associates LP

MetLife logo with Finance background

Bridgewater Associates LP boosted its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 151.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,198,030 shares of the financial services provider's stock after buying an additional 721,344 shares during the period. Bridgewater Associates LP owned 0.17% of MetLife worth $98,095,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Anchor Investment Management LLC lifted its holdings in shares of MetLife by 12.5% in the 3rd quarter. Anchor Investment Management LLC now owns 6,115 shares of the financial services provider's stock valued at $504,000 after acquiring an additional 681 shares during the last quarter. World Investment Advisors LLC bought a new stake in shares of MetLife in the 3rd quarter valued at approximately $336,000. Wilmington Savings Fund Society FSB purchased a new position in shares of MetLife in the 3rd quarter worth approximately $701,000. Tidal Investments LLC boosted its stake in MetLife by 3.9% during the third quarter. Tidal Investments LLC now owns 19,282 shares of the financial services provider's stock worth $1,590,000 after buying an additional 718 shares during the period. Finally, Synovus Financial Corp grew its holdings in MetLife by 5.5% during the 3rd quarter. Synovus Financial Corp now owns 22,720 shares of the financial services provider's stock valued at $1,874,000 after purchasing an additional 1,183 shares during the last quarter. Institutional investors own 94.99% of the company's stock.

MetLife Stock Up 1.1 %

Shares of NYSE MET traded up $0.79 during mid-day trading on Friday, reaching $72.49. 2,739,216 shares of the company were exchanged, compared to its average volume of 3,404,801. MetLife, Inc. has a 1 year low of $65.21 and a 1 year high of $89.05. The firm has a 50-day moving average of $79.41 and a 200 day moving average of $82.19. The stock has a market cap of $49.38 billion, a price-to-earnings ratio of 12.14, a P/E/G ratio of 0.65 and a beta of 0.89. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54.

MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Barclays dropped their price objective on MetLife from $95.00 to $88.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Cowen restated a "buy" rating on shares of MetLife in a report on Friday, March 7th. Morgan Stanley reduced their price target on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. Piper Sandler upped their target price on shares of MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Finally, BMO Capital Markets initiated coverage on shares of MetLife in a research note on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price target for the company. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $92.46.

View Our Latest Stock Analysis on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines